Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
781 to 800 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| R01GM116841 | Mechanism to regulate the length of small silencing RNAs | 1 | 2021 |
| R01GM120609 | Integrate cancer genomics data in genetic studies and diagnosis of developmental disorders | 1 | 2021 |
| R01GM127625 | Regulation of mitochondrial homeostasis through retrograde signaling | 1 | 2021 |
| R01GM129308 | Remodeling of the structure and function of the nuclear lamina by LINC complex-dependent tension | 1 | 2021 |
| R01GM129376 | Novel mechanism on subpopulation-dependent biased GPCR signaling in neurons | 1 | 2021 |
| R01HD090064 | The Hippocampus and Brainstem in the Sudden Infant Death Syndrome | 1 | 2021 |
| R01HL061483 | Axes of Oncometabolism in the Heart | 1 | 2021 |
| R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 1 | 2021 |
| R01HL111362 | Genomic and Proteomic Architecture of Atherosclerosis | 1 | 2021 |
| R01HL114120 | Endogenous and exogenous mechanisms that promote myocardial remuscularization in post infarction LV remodeling | 1 | 2021 |
| R01HL115580 | Integration of structure and signaling in cardiac pacemaker function | 1 | 2021 |
| R01HL118067 | Reductive Stress Induces Proteotoxic Cardiac Disease | 1 | 2021 |
| R01HL134893 | The Association of Metabolic Disease and Pulmonary Hypertension | 1 | 2021 |
| R01HL135121 | Clinical and Metabolic Signature of Recovered Myocardium in Human Heart Failure | 1 | 2021 |
| R01HL135129 | Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome | 1 | 2021 |
| R01HL136757 | Regulation of mitochondrial calcium uniporter in the heart | 1 | 2021 |
| R01HL138242 | Targeted Systemic Delivery of SDF-1 DNA for the Treatment of Chronic Heart Disease | 1 | 2021 |
| R01HL138466 | MACROPHAGE HETEROGENEITY IN HEART FAILURE PROGRESSION AND CARDIAC RECOVERY | 1 | 2021 |
| R01HL139335 | Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure | 1 | 2021 |
| R01HL139714 | MACROPHAGE ONTOGENY SHIFTS IN ISCHEMIC HEART DISEASE | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=40